WASHINGTON –(Business Wire)– Apr, 2010 The 2010 BIO International Convention will feature five super sessions focused on the state of the industry, global biotech advancements and policy trends. The sessions will feature high-level government speakers, including Director of the U.S. Patent and Trademark Office and Under Secretary of Commerce for Intellectual Property David Kappos and U.S. Food and Drug Administration Commissioner Margaret Hamburg as well as industry executives from Ernst and Young, the Campbell Alliance and Burrill & Company. The Convention will be held May 3-6, 2010 in Chicago, Ill. at McCormick Place.
“Like many industries, the biotechnology industry was significantly affected by global economic challenges in 2009 and, as the economy begins to recover, many are wondering where our industry stands today,” said Jim Greenwood, president and CEO of the Biotechnology Industry Organization. “The super sessions at Convention will provide attendees with a strong understanding of the state of the industry, including financial performance and mergers and acquisitions, challenges the industry will face in the coming year, and steps the industry is taking to recover.”
Super Sessions include: Leveraging IP to Spur Global Biotechnology Innovation, Investment and Jobs Date: Monday, May 3, 2:00 p.m. – 3:30 p.m. Biotech: The New Normal? Date: Monday, May 3, 4:00 p.m. – 5:30 p.m. Burrill State-of-the-Industry Report Date: Tuesday, May 4, 2:00 p.m. – 3:30 p.m. Advancing Regulatory Science: Bringing Progress to Patients Date: Tuesday, May 4, 4:00 p.m. – 5:30 p.m. Campbell Alliance 2010 Dealmakers’ Intentions Survey Date: Wednesday, May 5, 10:00 a.m. – 11:30 a.m. For detailed descriptions and a full program, please visit http://convention.bio.org. |